4WILLIAMS H C, BURNEY P G, PEMBROKE A C, et al. Vali- dation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. Diagnostic Criteria for Atopic Dermatitis Working Party[J]. Br J Dermatol, 1996, 135(1): 12-17.
5HAN1FIN J M, THURSTON M, OMOTO M, et al. The eczems area and severity index (EASI): assessment of reliabihy in atopic dermatitis[J]. Exp Dermatol, 2001, 10(1): 11-18.
6WOLFF S. Aspects of the adaptive response to very low doses of radiation and other agents[J]. Muta! Res, 1996, 358(2): 135-142.
7BOCCI V. Biological and clinical effects of ozone: has ozone therapy a future inmedieine[J]. Br J Bio.med Sci, 1999, 56(4): 270-279.
8BOCCI V, ZANARD1 I, TRAVAGLI V. Ozone a new therapeutic agent invascular diseases[J]. Am J Cardiovase Drugs, 2011, 11(2): 73-82.
9BOCCI V, BORRELLI E, TRAVAGLI V, et al. The ozone para- dox: ozone is a strong oxidant as well as a medical drug[J]. Med Res Rev, 2009, 29(4): 646-682.
10BUKHARI Z, MARSHALL M M, KORICH D G, et al.Comparison of cryptosporidium parvum viability and infectivity assays follow- ing ozone treatment of oocysts[J]. Appl Environ Microbiol, 2000, 66(7): 2972-2980.
